Bicocca Open Archive

Logo unimib boa
MONZA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.614
AS - Asia 7.698
EU - Europa 4.472
SA - Sud America 858
AF - Africa 145
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.398
VN - Vietnam 2.285
SG - Singapore 2.234
CN - Cina 1.371
IT - Italia 937
HK - Hong Kong 803
DE - Germania 798
RU - Federazione Russa 743
BR - Brasile 659
SE - Svezia 502
IE - Irlanda 320
GB - Regno Unito 307
IN - India 217
FR - Francia 214
KR - Corea 138
CA - Canada 135
UA - Ucraina 112
FI - Finlandia 109
ID - Indonesia 103
TR - Turchia 91
BD - Bangladesh 90
AR - Argentina 76
DK - Danimarca 71
JP - Giappone 69
ES - Italia 55
IQ - Iraq 55
NL - Olanda 55
AT - Austria 51
LT - Lituania 51
MX - Messico 51
ZA - Sudafrica 51
SA - Arabia Saudita 38
PL - Polonia 35
CO - Colombia 32
PK - Pakistan 31
BE - Belgio 30
EC - Ecuador 25
PH - Filippine 22
CH - Svizzera 21
VE - Venezuela 21
PY - Paraguay 19
MA - Marocco 17
ET - Etiopia 16
UZ - Uzbekistan 16
IR - Iran 15
MY - Malesia 14
KZ - Kazakistan 13
AU - Australia 11
EG - Egitto 11
TN - Tunisia 11
CL - Cile 10
CZ - Repubblica Ceca 10
NP - Nepal 10
AZ - Azerbaigian 9
KE - Kenya 9
TW - Taiwan 9
CR - Costa Rica 8
HR - Croazia 8
JO - Giordania 8
RO - Romania 8
DZ - Algeria 7
IL - Israele 7
KG - Kirghizistan 7
BG - Bulgaria 6
PA - Panama 6
RS - Serbia 6
UY - Uruguay 6
AO - Angola 5
EU - Europa 5
GR - Grecia 5
OM - Oman 5
PE - Perù 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BH - Bahrain 4
BO - Bolivia 4
JM - Giamaica 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AL - Albania 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
MM - Myanmar 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LB - Libano 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 22.788
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.890
Singapore 1.388
Dallas 855
Ashburn 837
Hong Kong 775
Ho Chi Minh City 667
San Jose 659
Hanoi 572
Frankfurt am Main 517
Wilmington 368
Milan 363
Chandler 358
Woodbridge 314
Dublin 310
Los Angeles 253
New York 250
Dearborn 246
Fairfield 213
Houston 193
Santa Clara 187
Beijing 171
Princeton 140
Chicago 137
Nanjing 116
Seoul 110
The Dalles 108
Jacksonville 107
Hefei 105
Seattle 102
Boardman 95
Lauterbourg 78
Shanghai 76
Da Nang 75
Council Bluffs 74
Jakarta 73
Guangzhou 72
Buffalo 69
Moscow 68
Cambridge 65
Haiphong 61
Orem 61
Helsinki 58
São Paulo 58
Munich 50
Dong Ket 49
Biên Hòa 44
Basingstoke 43
Ha Long 42
Vilnius 40
Nanchang 38
Tokyo 38
Vienna 36
Hải Dương 35
Ninh Bình 35
Nuremberg 35
Bắc Giang 34
Hangzhou 33
Lawrence 33
Montreal 33
Pune 33
Altamura 32
Denver 32
Quận Bình Thạnh 32
Toronto 32
Can Tho 31
Shenyang 31
Chennai 30
Vũng Tàu 29
Baghdad 28
Warsaw 28
London 27
Rome 27
Zhengzhou 27
Atlanta 26
Brooklyn 25
Rio de Janeiro 25
Carate Brianza 24
Johannesburg 24
Thái Nguyên 24
Tianjin 24
Brussels 23
Phoenix 22
Ottawa 21
Poplar 21
Shangdi 21
Stockholm 21
Manchester 20
Phủ Lý 20
Quận Một 20
Andover 19
Fremont 19
Kunming 19
San Diego 19
Turku 19
Changsha 18
Kent 18
Quận Phú Nhuận 18
San Francisco 18
Bắc Ninh 17
Kocaeli 17
Totale 14.893
Salva come PNG Salva come JPEG
Nome #
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 569
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 540
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 537
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 483
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 471
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 445
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 415
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 403
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 390
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 389
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 377
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 368
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 367
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 364
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 358
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 353
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 339
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 337
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 337
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 328
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 315
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 312
In vitro models for studying oxaliplatin neurotoxic effects 310
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 308
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 307
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 305
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 299
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 299
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 297
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 294
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 293
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 292
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 290
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 289
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 285
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 280
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 278
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 274
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 272
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 271
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 269
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 268
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 268
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 267
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 261
Multimodal experimental approach to the study of human neurological diseases 260
Thermal plantar test in experimental ischemic stroke 254
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 252
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 243
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 242
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 236
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 231
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 225
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 222
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 221
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 221
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 220
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 218
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 216
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 215
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 212
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 208
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 207
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 204
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 201
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 201
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 200
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 198
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 198
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 191
Pharmacokinetics of IVIg in Wistar rats 189
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 189
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 188
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 188
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 186
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 181
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 175
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 165
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 164
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 161
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 157
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 153
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain 152
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 149
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 148
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 121
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 118
Totale 23.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.873
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021399 0 0 0 0 0 0 0 0 0 0 161 238
2021/20221.207 122 164 133 116 84 96 60 54 49 63 84 182
2022/20231.828 198 362 223 187 155 304 58 84 120 31 64 42
2023/20241.293 56 46 59 76 144 292 191 75 63 32 40 219
2024/20253.884 163 470 343 160 320 141 300 138 422 582 318 527
2025/202610.133 2.150 1.027 1.215 871 992 538 1.477 397 676 785 5 0
Totale 23.653